Intracerebral Hemorrhage Due to Oral Anticoagulants: Prediction of the Risk by Magnetic Resonance

• Status: Completed
• Trial end date: 2017-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether Magnetic Resonance Imaging may predict the risk of Intracerebral Hemorrhage for patients with ischemic stroke who receive indefinite oral anticoagulation

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
• Treatments: Anticoagulants; Apixaban; Dabigatran; Rivaroxaban; Warfarin

Criteria

Inclusion Criteria:

1. Age > 65 y

2. TIA or ischemic stroke

3. The patient will receive indefinitely treatment with oral anticoagulants for the secondary prevention of cardioembolic stroke

4. No previous treatment with oral anticoagulants

5. Signed consent before performing a Magnetic Resonance

6. Long-term follow-up will be possible

Exclusion Criteria:

1. The patient will receive oral anticoagulation as a primary prevention treatment

2. The etiology that motivates the onset of oral anticoagulants is not cardioembolism

3. Absolute contraindication to receive oral anticoagulants

4. Arterial hypertension that is not controlled, hypertensive crisis

5. Dementia

6. Live-expectancy less than 1 year

7. Any social or psychological reason that prevents follow-up

8. Contraindication to perform a Magnetic Resonance examination

9. Patients who received oral antiacoagulants prior to the current stroke

10. The Magnetic Resonance imaging was performed more than 1 month after the onset of treatment with oral anticoagulants